No BS Just Facts logo
No BS Just Facts
It might be boring, but it's just the facts.

← All stories · business

MarketWatch

The FDA declined to approve one of biotech’s most closely watched cancer drugs

Monday, November 16, 2026


The FDA declined to approve Summit Therapeutics' lung cancer drug, stating that the company must demonstrate the medication extends patient survival. Summit Therapeutics had submitted the drug for FDA review. The regulator's decision requires additional clinical data before reconsidering approval.

Original reporting:

Next story

Pompeii home buried by Mount Vesuvius yields personal treasures untouched for nearly 2,000 years→